To include your compound in the COVID-19 Resource Center, submit it here.

Provenge sipuleucel-T regulatory update

The Centers for Medicare & Medicaid Services issued a National Coverage Determination (NCD) supporting coverage of cancer drug Provenge sipuleucel-T from Dendreon

Read the full 228 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE